Key facts
- Notable investors include Ahn Sang.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for VivaLabs
- ·The full record, as it builds
Funding rounds
No funding rounds for VivaLabs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About VivaLabs
Developer of a health tech platform designed to analyze senior health data with the help of AI technology. The company offers an AI-based personalized exercise prescription system to provide scientific strength training programs, exercise modules designed by exercise and medical experts and helps to track individual progress, enabling users to get online fitness trainings and stay in a healthy atmosphere.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Gwangju Metropolitan City, South Korea
- Founded
- 2024
- Employees
- 3
- Website
- vivalabs.kr/
- Ownership
- Privately Held (backing)
VivaLabs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in VivaLabs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on VivaLabs in its N-PORT filings yet. We sweep new filings monthly.